These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30069487)

  • 1. Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients.
    Niki M; Yoshiyama T; Miyamoto Y; Okumura M; Niki M; Oinuma KI; Kaneko Y; Matsumoto S; Sasaki Y; Ogata H; Goto H; Kudoh S; Hoshino Y
    J Immunol Res; 2018; 2018():4928757. PubMed ID: 30069487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.
    Niki M; Suzukawa M; Akashi S; Nagai H; Ohta K; Inoue M; Niki M; Kaneko Y; Morimoto K; Kurashima A; Kitada S; Matsumoto S; Suzuki K; Hoshino Y
    J Immunol Res; 2015; 2015():527395. PubMed ID: 26568961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies and tuberculosis: finally coming of age?
    Li H; Javid B
    Nat Rev Immunol; 2018 Sep; 18(9):591-596. PubMed ID: 29872140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
    Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
    Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.
    Coppola M; Arroyo L; van Meijgaarden KE; Franken KL; Geluk A; Barrera LF; Ottenhoff THM
    Tuberculosis (Edinb); 2017 Sep; 106():25-32. PubMed ID: 28802401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response against mycobacterial antigens in children with tuberculosis.
    Demkow U; Ziołkowski J; Białas-Chromiec B; Filewska M; Zielonka T; Wasik M; Rowińska-Zakrzewska E
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():63-73. PubMed ID: 17072031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection.
    Trentini MM; de Oliveira FM; Gaeti MP; Batista AC; Lima EM; Kipnis A; Junqueira-Kipnis AP
    Vaccine; 2014 Jul; 32(34):4324-32. PubMed ID: 24951861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated immunity against tuberculosis: implications for vaccine development.
    Achkar JM; Casadevall A
    Cell Host Microbe; 2013 Mar; 13(3):250-62. PubMed ID: 23498951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
    Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
    Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
    Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
    Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
    Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
    Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.
    Achkar JM; Prados-Rosales R
    Curr Opin Immunol; 2018 Aug; 53():30-37. PubMed ID: 29656063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy.
    Glatman-Freedman A
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):9-16. PubMed ID: 14556990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB.
    Awoniyi DO; Baumann R; Chegou NN; Kriel B; Jacobs R; Kidd M; Loxton AG; Kaempfer S; Singh M; Walzl G
    Oncotarget; 2017 Jun; 8(23):37525-37537. PubMed ID: 28415587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
    Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
    J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis.
    Parra M; Pickett T; Delogu G; Dheenadhayalan V; Debrie AS; Locht C; Brennan MJ
    Infect Immun; 2004 Dec; 72(12):6799-805. PubMed ID: 15557600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
    Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
    Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.